These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 24858712)

  • 1. MiR-20a is upregulated in anaplastic thyroid cancer and targets LIMK1.
    Xiong Y; Zhang L; Kebebew E
    PLoS One; 2014; 9(5):e96103. PubMed ID: 24858712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-20a inhibits cutaneous squamous cell carcinoma metastasis and proliferation by directly targeting LIMK1.
    Zhou J; Liu R; Luo C; Zhou X; Xia K; Chen X; Zhou M; Zou Q; Cao P; Cao K
    Cancer Biol Ther; 2014 Oct; 15(10):1340-9. PubMed ID: 25019203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-886-3p regulates cell proliferation and migration, and is dysregulated in familial non-medullary thyroid cancer.
    Xiong Y; Zhang L; Holloway AK; Wu X; Su L; Kebebew E
    PLoS One; 2011; 6(10):e24717. PubMed ID: 21998631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-206 inhibits metastasis-relevant traits by degrading MRTF-A in anaplastic thyroid cancer.
    Zhang WL; Lv W; Sun SZ; Wu XZ; Zhang JH
    Int J Oncol; 2015 Jul; 47(1):133-42. PubMed ID: 25955685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA 483-3p targets Pard3 to potentiate TGF-β1-induced cell migration, invasion, and epithelial-mesenchymal transition in anaplastic thyroid cancer cells.
    Zhang X; Liu L; Deng X; Li D; Cai H; Ma Y; Jia C; Wu B; Fan Y; Lv Z
    Oncogene; 2019 Jan; 38(5):699-715. PubMed ID: 30171257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knockdown of HCP5 exerts tumor-suppressive functions by up-regulating tumor suppressor miR-128-3p in anaplastic thyroid cancer.
    Chen J; Zhao D; Meng Q
    Biomed Pharmacother; 2019 Aug; 116():108966. PubMed ID: 31102936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-125b inhibits anaplastic thyroid cancer cell migration and invasion by targeting PIK3CD.
    Bu Q; You F; Pan G; Yuan Q; Cui T; Hao L; Zhang J
    Biomed Pharmacother; 2017 Apr; 88():443-448. PubMed ID: 28122310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-155 promotes anaplastic thyroid cancer progression by directly targeting SOCS1.
    Zhang W; Ji W; Zhao X
    BMC Cancer; 2019 Nov; 19(1):1093. PubMed ID: 31718618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-126-3p Inhibits Thyroid Cancer Cell Growth and Metastasis, and Is Associated with Aggressive Thyroid Cancer.
    Xiong Y; Kotian S; Zeiger MA; Zhang L; Kebebew E
    PLoS One; 2015; 10(8):e0130496. PubMed ID: 26244545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thyroid Follicular Cell Loss of Differentiation Induced by MicroRNA miR-17-92 Cluster Is Attenuated by CRISPR/Cas9n Gene Silencing in Anaplastic Thyroid Cancer.
    Fuziwara CS; Saito KC; Kimura ET
    Thyroid; 2020 Jan; 30(1):81-94. PubMed ID: 31578932
    [No Abstract]   [Full Text] [Related]  

  • 11. MicroRNA-138 inhibits migration and invasion of non-small cell lung cancer cells by targeting LIMK1.
    Tan Y; Hu H; Tan W; Jin L; Liu J; Zhou H
    Mol Med Rep; 2016 Nov; 14(5):4422-4428. PubMed ID: 27665963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long noncoding RNA MALAT1 knockdown inhibits progression of anaplastic thyroid carcinoma by regulating miR-200a-3p/FOXA1.
    Gou L; Zou H; Li B
    Cancer Biol Ther; 2019; 20(11):1355-1365. PubMed ID: 31500506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered expression of mir-222 and mir-25 influences diverse gene expression changes in transformed normal and anaplastic thyroid cells, and impacts on MEK and TRAIL protein expression.
    Aherne ST; Smyth P; Freeley M; Smith L; Spillane C; O'Leary J; Sheils O
    Int J Mol Med; 2016 Aug; 38(2):433-45. PubMed ID: 27353001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exosomal lncRNA H19 promotes the progression of hepatocellular carcinoma treated with Propofol via miR-520a-3p/LIMK1 axis.
    Wang D; Xing N; Yang T; Liu J; Zhao H; He J; Ai Y; Yang J
    Cancer Med; 2020 Oct; 9(19):7218-7230. PubMed ID: 32767662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TWIST1/miR-584/TUSC2 pathway induces resistance to apoptosis in thyroid cancer cells.
    Orlandella FM; Di Maro G; Ugolini C; Basolo F; Salvatore G
    Oncotarget; 2016 Oct; 7(43):70575-70588. PubMed ID: 27661106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long noncoding RNA UCA1 promotes anaplastic thyroid cancer cell proliferation via miR‑135a‑mediated c‑myc activation.
    Wang Y; Hou Z; Li D
    Mol Med Rep; 2018 Sep; 18(3):3068-3076. PubMed ID: 30015867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-577 inhibits papillary thyroid carcinoma cell proliferation, migration and invasion by targeting SphK2.
    Xue KC; Hu DD; Zhao L; Li N; Shen HY
    Eur Rev Med Pharmacol Sci; 2017 Oct; 21(17):3794-3800. PubMed ID: 28975989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-429-5p attenuates the migration and invasion of malignant melanoma by targeting LIMK1.
    Sheng H; Guo YH; Cao DS; Li XJ; Zhao Y; Ding H; Zhang YL; Chen ZH
    Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2625-2631. PubMed ID: 32196612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-143 inhibits NSCLC cell growth and metastasis by targeting Limk1.
    Xia H; Sun S; Wang B; Wang T; Liang C; Li G; Huang C; Qi D; Chu X
    Int J Mol Sci; 2014 Jul; 15(7):11973-83. PubMed ID: 25003638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-4295 promotes cell proliferation and invasion in anaplastic thyroid carcinoma via CDKN1A.
    Shao M; Geng Y; Lu P; Xi Y; Wei S; Wang L; Fan Q; Ma W
    Biochem Biophys Res Commun; 2015 Sep; 464(4):1309-1313. PubMed ID: 26231799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.